MedTrace Logo

Intense Regulated Pulsed Light Vs Standard of Care for the Treatment of Meibomian Gland Dysfunction

NCT04920396 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-04-23

No results posted yet for this study

Summary

This study is to evaluate the effectiveness of E\>EYE intense regulated pulsed light (IRPL) treatment compared to the current standard of care using a daily warm compress

Conditions

  • Meibomian Gland Dysfunction

Interventions

DEVICE

E>Eye IRPL

Regulated intense pulsed light therapy

DEVICE

Warm compress

Fabric mask with anti-bacterial coating filled with BodyBeads® heated in a microwave for 30 seconds before application over the eyes for 5 minutes

Sponsors & Collaborators

  • Aston University

    lead OTHER

Principal Investigators

  • James Wolffsohn, PhD · Aston University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-08
Primary Completion
2026-02-16
Completion
2026-12-16

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04920396 on ClinicalTrials.gov